Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 16 | 2018 | 122 | 4.400 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 6 | 2018 | 47 | 1.530 |
Why?
|
| Influenza Vaccines | 7 | 2018 | 78 | 1.440 |
Why?
|
| Orthomyxoviridae | 2 | 2014 | 14 | 0.900 |
Why?
|
| Child, Preschool | 18 | 2018 | 1270 | 0.840 |
Why?
|
| Influenza B virus | 4 | 2018 | 20 | 0.730 |
Why?
|
| Pneumococcal Vaccines | 4 | 2015 | 26 | 0.690 |
Why?
|
| Streptococcus pneumoniae | 5 | 2015 | 40 | 0.680 |
Why?
|
| Infant | 14 | 2016 | 1062 | 0.660 |
Why?
|
| Child | 16 | 2018 | 2442 | 0.640 |
Why?
|
| Pneumococcal Infections | 4 | 2015 | 31 | 0.630 |
Why?
|
| Emergency Service, Hospital | 4 | 2016 | 474 | 0.600 |
Why?
|
| Vaccination | 4 | 2018 | 138 | 0.600 |
Why?
|
| Adolescent | 14 | 2018 | 3568 | 0.530 |
Why?
|
| Whooping Cough | 2 | 2012 | 11 | 0.500 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2012 | 8 | 0.500 |
Why?
|
| Aerosols | 2 | 2013 | 14 | 0.500 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 12 | 0.490 |
Why?
|
| Family Characteristics | 2 | 2014 | 36 | 0.490 |
Why?
|
| Age Distribution | 1 | 2014 | 206 | 0.460 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 58 | 0.460 |
Why?
|
| North Carolina | 7 | 2016 | 1538 | 0.450 |
Why?
|
| Immunization | 1 | 2013 | 33 | 0.440 |
Why?
|
| Inhalation Exposure | 1 | 2013 | 9 | 0.430 |
Why?
|
| Critical Care | 1 | 2014 | 106 | 0.430 |
Why?
|
| Air Microbiology | 1 | 2013 | 18 | 0.430 |
Why?
|
| Medical Records | 1 | 2013 | 76 | 0.430 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 12 | 0.430 |
Why?
|
| Influenza A virus | 1 | 2012 | 22 | 0.430 |
Why?
|
| Antiviral Agents | 1 | 2013 | 108 | 0.430 |
Why?
|
| Immunization Programs | 1 | 2012 | 26 | 0.410 |
Why?
|
| Respiratory Protective Devices | 1 | 2011 | 3 | 0.390 |
Why?
|
| Registries | 1 | 2013 | 298 | 0.390 |
Why?
|
| Eye Infections, Viral | 1 | 2011 | 3 | 0.390 |
Why?
|
| Male | 18 | 2018 | 19217 | 0.370 |
Why?
|
| Primary Health Care | 1 | 2013 | 227 | 0.370 |
Why?
|
| Humans | 29 | 2018 | 32114 | 0.370 |
Why?
|
| Female | 18 | 2018 | 20015 | 0.360 |
Why?
|
| Hospitalization | 2 | 2012 | 470 | 0.350 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 4 | 2018 | 23 | 0.350 |
Why?
|
| Young Adult | 7 | 2018 | 2665 | 0.340 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 10 | 0.290 |
Why?
|
| Adult | 8 | 2018 | 9380 | 0.260 |
Why?
|
| Infant, Newborn | 4 | 2016 | 672 | 0.250 |
Why?
|
| Prospective Studies | 6 | 2018 | 2283 | 0.240 |
Why?
|
| Middle Ear Ventilation | 2 | 2015 | 9 | 0.230 |
Why?
|
| Haemophilus influenzae | 2 | 2015 | 14 | 0.230 |
Why?
|
| Otitis Media with Effusion | 2 | 2015 | 12 | 0.230 |
Why?
|
| Middle Aged | 7 | 2016 | 11839 | 0.230 |
Why?
|
| Immunization Schedule | 3 | 2012 | 26 | 0.210 |
Why?
|
| RNA, Viral | 2 | 2013 | 48 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 263 | 0.200 |
Why?
|
| Parents | 2 | 2012 | 147 | 0.180 |
Why?
|
| Time Factors | 3 | 2015 | 2151 | 0.180 |
Why?
|
| Otitis Media | 2 | 2015 | 23 | 0.180 |
Why?
|
| Ear, Middle | 2 | 2015 | 9 | 0.160 |
Why?
|
| United States | 7 | 2018 | 3976 | 0.150 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 40 | 0.150 |
Why?
|
| Vaccines, Attenuated | 4 | 2018 | 11 | 0.150 |
Why?
|
| Vaccines, Inactivated | 4 | 2018 | 38 | 0.150 |
Why?
|
| Population Surveillance | 2 | 2015 | 125 | 0.140 |
Why?
|
| Body Weight | 1 | 2018 | 310 | 0.130 |
Why?
|
| Models, Theoretical | 2 | 2015 | 137 | 0.130 |
Why?
|
| Overweight | 1 | 2018 | 280 | 0.130 |
Why?
|
| Carnobacteriaceae | 1 | 2015 | 3 | 0.130 |
Why?
|
| Clinical Medicine | 1 | 2015 | 12 | 0.130 |
Why?
|
| Mastoiditis | 1 | 2015 | 2 | 0.130 |
Why?
|
| Mastoid | 1 | 2015 | 2 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2015 | 51 | 0.120 |
Why?
|
| Viral Proteins | 2 | 2004 | 35 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 128 | 0.110 |
Why?
|
| Sneezing | 1 | 2013 | 7 | 0.110 |
Why?
|
| Nasopharynx | 1 | 2013 | 8 | 0.110 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 9 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 198 | 0.110 |
Why?
|
| Cough | 1 | 2013 | 19 | 0.110 |
Why?
|
| Limit of Detection | 1 | 2012 | 15 | 0.110 |
Why?
|
| Viral Load | 1 | 2013 | 70 | 0.110 |
Why?
|
| Gram-Positive Cocci | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cross Infection | 1 | 2013 | 55 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2012 | 33 | 0.100 |
Why?
|
| Rotavirus Vaccines | 1 | 2012 | 6 | 0.100 |
Why?
|
| Rotavirus Infections | 1 | 2012 | 9 | 0.100 |
Why?
|
| Tonsillitis | 1 | 2012 | 6 | 0.100 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 7 | 0.100 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 16 | 0.100 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 22 | 0.100 |
Why?
|
| Health Personnel | 1 | 2013 | 121 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 18 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2012 | 186 | 0.100 |
Why?
|
| Health Policy | 1 | 2012 | 89 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 582 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 172 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 881 | 0.080 |
Why?
|
| Pregnancy | 1 | 2012 | 997 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 357 | 0.080 |
Why?
|
| Virus Replication | 2 | 2004 | 42 | 0.070 |
Why?
|
| Alaska | 1 | 2007 | 2 | 0.070 |
Why?
|
| Inuits | 1 | 2007 | 2 | 0.070 |
Why?
|
| Serotyping | 1 | 2007 | 19 | 0.070 |
Why?
|
| Indians, North American | 1 | 2007 | 109 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 898 | 0.070 |
Why?
|
| Gene Products, gag | 1 | 2005 | 2 | 0.060 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Virus Assembly | 1 | 2005 | 4 | 0.060 |
Why?
|
| Endosomes | 1 | 2005 | 12 | 0.060 |
Why?
|
| Animals | 3 | 2014 | 7542 | 0.060 |
Why?
|
| RNA Replicase | 1 | 2004 | 1 | 0.060 |
Why?
|
| Rhadinovirus | 1 | 2004 | 4 | 0.060 |
Why?
|
| HIV-1 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Reoviridae | 1 | 2003 | 2 | 0.060 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2003 | 4 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2003 | 5 | 0.060 |
Why?
|
| Bacterial Capsules | 1 | 2002 | 4 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 18 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2002 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3306 | 0.040 |
Why?
|
| Nose | 1 | 2018 | 12 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 91 | 0.040 |
Why?
|
| Pharynx | 1 | 2017 | 14 | 0.040 |
Why?
|
| Acute Disease | 1 | 2018 | 253 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3990 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 783 | 0.030 |
Why?
|
| Suppuration | 1 | 2015 | 6 | 0.030 |
Why?
|
| Penicillins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 80 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 43 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 5 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 14 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 79 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2015 | 3510 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 220 | 0.030 |
Why?
|
| Gastroenteritis | 1 | 2012 | 12 | 0.030 |
Why?
|
| Healthy People Programs | 1 | 2012 | 3 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 2012 | 11 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2012 | 27 | 0.030 |
Why?
|
| Biofilms | 1 | 2012 | 24 | 0.030 |
Why?
|
| Electronic Mail | 1 | 2012 | 18 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 91 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 98 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 88 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 10314 | 0.020 |
Why?
|
| Social Behavior | 1 | 2012 | 65 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 263 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 185 | 0.020 |
Why?
|
| Universities | 1 | 2012 | 150 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 464 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 198 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1176 | 0.020 |
Why?
|
| Students | 1 | 2012 | 178 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2008 | 17 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1189 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 408 | 0.020 |
Why?
|
| Transport Vesicles | 1 | 2005 | 1 | 0.020 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2005 | 1 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 32 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2005 | 34 | 0.020 |
Why?
|
| Protein Transport | 1 | 2005 | 74 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 99 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2004 | 11 | 0.020 |
Why?
|
| Protein Binding | 1 | 2005 | 201 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1817 | 0.020 |
Why?
|
| Rabbits | 1 | 2004 | 197 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2003 | 5 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 14 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 191 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 435 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 2484 | 0.010 |
Why?
|